Fingerprint
Dive into the research topics of 'Gemcitabine and docetaxel for hepatocellular carcinoma: A phase II north central cancer treatment group clinical trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Gemcitabine and docetaxel for hepatocellular carcinoma: A phase II north central cancer treatment group clinical trial
Steven R. Alberts, Joel M. Reid, Bruce W. Morlan, Gist H. Farr, John K. Camoriano, David B. Johnson, James R. Enger, Thomas E. Seay, George P. Kim
Research output: Contribution to journal › Article › peer-review
11
Scopus
citations